Dr. Stanley Tu, M.D

NPI: 1215011879
Total Payments
$2,747
2024 Payments
$1,036
Companies
32
Transactions
127
Medicare Patients
4,212
Medicare Billing
$568,781

Payment Breakdown by Category

Food & Beverage$2,747 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,747 127 100.0%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $417.18 20 $0 (2024)
HARMONY BIOSCIENCES LLC $362.65 11 $0 (2024)
Grifols USA, LLC $297.29 12 $0 (2024)
GlaxoSmithKline, LLC. $238.71 14 $0 (2024)
Merck Sharp & Dohme LLC $183.14 9 $0 (2024)
Regeneron Healthcare Solutions, Inc. $145.98 6 $0 (2024)
United Therapeutics Corporation $92.97 4 $0 (2024)
Novo Nordisk Inc $91.59 5 $0 (2024)
Axsome Therapeutics, Inc. $86.15 4 $0 (2024)
Mylan Specialty L.P. $62.45 4 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,036 44 HARMONY BIOSCIENCES LLC ($150.37)
2023 $670.11 29 Grifols USA, LLC ($101.50)
2022 $544.34 24 Harmony Biosciences LLC ($132.87)
2021 $120.58 7 Bausch Health US, LLC ($35.11)
2020 $80.34 5 Boehringer Ingelheim Pharmaceuticals, Inc. ($49.04)
2019 $138.45 8 Mylan Specialty L.P. ($28.65)
2018 $45.09 2 Sanofi Pasteur Inc. ($24.77)
2017 $111.96 8 GlaxoSmithKline, LLC. ($68.75)

All Payment Transactions

127 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/13/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $21.61 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
11/21/2024 Harmony Biosciences Llc WAKIX (Drug) Food and Beverage Cash or cash equivalent $33.50 General
Category: Narcoplepsy
11/04/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $22.41 General
Category: INFECTIOUS DISEASE
10/31/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $27.88 General
Category: RESPIRATORY
10/29/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $30.92 General
Category: Pulmonology
10/23/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $37.25 General
Category: NEUROLOGY
10/22/2024 PFIZER INC. PREVNAR 20 (Biological) Food and Beverage In-kind items and services $20.44 General
Category: VACCINES
10/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $21.59 General
Category: RESPIRATORY
10/15/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $24.90 General
Category: NEUROLOGY
10/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $25.20 General
Category: RESPIRATORY
09/12/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $41.12 General
Category: Narcoplepsy
08/30/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.30 General
Category: Diabetes
08/29/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.65 General
Category: RESPIRATORY
08/27/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $20.43 General
Category: IMMUNOLOGY
08/15/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $12.70 General
Category: RESPIRATORY
08/01/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $13.79 General
Category: HFCWO
07/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.53 General
Category: RESPIRATORY
07/29/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $27.69 General
Category: Pulmonology
07/25/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $20.69 General
Category: IMMUNOLOGY
07/23/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $25.59 General
Category: IMMUNOLOGY
07/11/2024 Baxter Healthcare Hillrom - Monarch Airway Clearance System (Device) Food and Beverage In-kind items and services $31.01 General
Category: Airway Clearance Device
07/09/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $18.07 General
Category: Otolaryngology (Ear, Nose, Throat)
07/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $20.32 General
Category: RESPIRATORY
06/28/2024 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $21.01 General
Category: INFECTIOUS DISEASE
05/31/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $24.27 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 950 1,416 $297,150 $150,749
2022 6 972 1,500 $305,560 $152,924
2021 11 1,081 1,499 $276,615 $140,333
2020 12 1,209 1,670 $287,600 $124,776
Total Patients
4,212
Total Services
6,085
Medicare Billing
$568,781
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 245 466 $128,150 $63,670 49.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 230 230 $50,600 $32,283 63.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 208 293 $60,080 $28,184 46.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 211 369 $51,660 $24,805 48.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $4,725 $1,287 27.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 41 43 $1,935 $519.06 26.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 214 359 $98,725 $48,763 49.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 290 488 $100,040 $45,957 45.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 225 409 $57,260 $27,739 48.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 191 191 $42,020 $27,698 65.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $5,985 $2,345 39.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 33 34 $1,530 $421.50 27.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 330 619 $127,005 $58,588 46.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 183 236 $64,900 $32,087 49.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 150 150 $33,000 $22,350 67.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 149 218 $30,520 $15,617 51.2%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 76 76 $5,475 $4,539 82.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 22 22 $6,930 $2,905 41.9%
G0008 Administration of influenza virus vaccine Office 2021 78 78 $3,900 $1,519 39.0%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2021 11 11 $1,430 $1,367 95.6%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 47 53 $1,740 $633.09 36.4%
G0009 Administration of pneumococcal vaccine Office 2021 19 19 $950.00 $365.04 38.4%
71045 X-ray of chest, 1 view Office 2021 16 17 $765.00 $361.65 47.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 369 712 $145,960 $57,107 39.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 147 177 $48,675 $18,234 37.5%

About Dr. Stanley Tu, M.D

Dr. Stanley Tu, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215011879.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Tu, M.D has received a total of $2,747 in payments from pharmaceutical and medical device companies, with $1,036 received in 2024. These payments were reported across 127 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,747).

As a Medicare-enrolled provider, Tu has provided services to 4,212 Medicare beneficiaries, totaling 6,085 services with total Medicare billing of $568,781. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Pasadena, CA
  • Active Since 10/24/2006
  • Last Updated 07/27/2012
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1215011879

Products in Payments

  • Prolastin-C Liquid (Biological) $297.29
  • OFEV (Drug) $281.06
  • WAKIX (Drug) $229.78
  • DUPIXENT (Biological) $208.37
  • DIFICID (Drug) $150.85
  • Wakix (Drug) $132.87
  • STIOLTO RESPIMAT (Drug) $121.73
  • TRELEGY ELLIPTA (Drug) $112.66
  • TYVASO (Drug) $92.97
  • Sunosi (Drug) $86.15
  • Yupelri (Drug) $62.45
  • PREVNAR 20 (Biological) $59.92
  • Rybelsus (Drug) $58.20
  • ANORO (Drug) $53.29
  • APLENZIN (Drug) $48.03
  • PURIFIED CORTROPHIN GEL (Drug) $46.77
  • LUMRYZ (Drug) $46.28
  • ACTHAR (Biological) $46.02
  • NUCALA (Biological) $44.12
  • QUVIVIQ (Drug) $37.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Pasadena